• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞和抗体动力学描绘了 COVID-19 恢复期个体中介导长期免疫反应的 SARS-CoV-2 肽。

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.

机构信息

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.

Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tübingen, Germany.

出版信息

Sci Transl Med. 2021 Apr 21;13(590). doi: 10.1126/scitranslmed.abf7517. Epub 2021 Mar 15.

DOI:10.1126/scitranslmed.abf7517
PMID:33723016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8128286/
Abstract

Long-term immunological memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for the development of population-level immunity, which is the aim of vaccination approaches. Reports on rapidly decreasing antibody titers have led to questions regarding the efficacy of humoral immunity alone. The relevance of T cell memory after coronavirus disease 2019 (COVID-19) remains unclear. Here, we investigated SARS-CoV-2 antibody and T cell responses in matched samples of COVID-19 convalescent individuals up to 6 months after infection. Longitudinal analysis revealed decreasing and stable spike- and nucleocapsid-specific antibody responses, respectively. In contrast, functional T cell responses remained robust, and even increased, in both frequency and intensity. Single peptide mapping of T cell diversity over time identified open reading frame-independent, dominant T cell epitopes mediating long-term SARS-CoV-2 T cell responses. Identification of these epitopes may be fundamental for COVID-19 vaccine design.

摘要

针对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的长期免疫记忆对于人群水平免疫的发展至关重要,这是疫苗接种方法的目标。有关抗体滴度迅速下降的报告引发了对单独体液免疫功效的质疑。新冠肺炎(COVID-19)后 T 细胞记忆的相关性尚不清楚。在这里,我们在感染后长达 6 个月的时间里,对 COVID-19 康复个体的匹配样本进行了 SARS-CoV-2 抗体和 T 细胞反应研究。纵向分析显示,分别为刺突蛋白和核衣壳特异性抗体反应下降和稳定。相比之下,功能 T 细胞反应的频率和强度均保持强劲,甚至增加。随着时间的推移,对 T 细胞多样性的单肽作图鉴定了与开放阅读框无关的、主导 SARS-CoV-2 T 细胞反应的 T 细胞表位。鉴定这些表位可能是 COVID-19 疫苗设计的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/587186f35210/abf7517-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/3a71596d53f3/abf7517-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/c08397ebe379/abf7517-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/878f210d0734/abf7517-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/587186f35210/abf7517-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/3a71596d53f3/abf7517-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/c08397ebe379/abf7517-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/878f210d0734/abf7517-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8a/8128286/587186f35210/abf7517-F4.jpg

相似文献

1
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.T 细胞和抗体动力学描绘了 COVID-19 恢复期个体中介导长期免疫反应的 SARS-CoV-2 肽。
Sci Transl Med. 2021 Apr 21;13(590). doi: 10.1126/scitranslmed.abf7517. Epub 2021 Mar 15.
2
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.鉴定 SARS-CoV-2 核衣壳和刺突 T 细胞表位以评估 T 细胞免疫。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02002-20.
3
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.针对 SARS-CoV-2 核衣壳表位具有特异性的 CD8 T 细胞表现出高的初始前体频率和 TCR 多样性。
Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15.
4
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.SARS-CoV-2 感染后长达 9 个月的稳健且具有功能性的免疫记忆:一项东南亚纵向队列研究。
Front Immunol. 2022 Feb 3;13:817905. doi: 10.3389/fimmu.2022.817905. eCollection 2022.
5
SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.SARS-CoV-2 感染严重程度与针对刺突蛋白的体液免疫优势相关。
mBio. 2021 Jan 19;12(1):e02940-20. doi: 10.1128/mBio.02940-20.
6
Human CD4 T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential.人类针对 SARS-CoV-2 刺突蛋白和核衣壳蛋白优势表位的 CD4 T 细胞具有治疗潜力。
Clin Exp Immunol. 2021 Sep;205(3):363-378. doi: 10.1111/cei.13627. Epub 2021 Jun 29.
7
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
8
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.在 COVID-19 康复者中鉴定出的 SARS-CoV-2 特异性记忆 T 细胞表位。
Virus Res. 2021 Oct 15;304:198508. doi: 10.1016/j.virusres.2021.198508. Epub 2021 Jul 27.
9
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.与单纯 SARS-CoV-2 感染的儿童相比,患有儿童多系统炎症综合征的儿童的 SARS-CoV-2 特异性 T 细胞反应更强。
Front Immunol. 2022 Jan 18;12:793197. doi: 10.3389/fimmu.2021.793197. eCollection 2021.
10
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.COVID-19 急性和恢复期患者对 SARS-CoV-2 膜蛋白的抗体反应。
Front Immunol. 2021 Aug 4;12:679841. doi: 10.3389/fimmu.2021.679841. eCollection 2021.

引用本文的文献

1
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families.新冠病毒暴露家庭中体液免疫和细胞免疫的纵向分析。
Sci Rep. 2025 Jul 18;15(1):26041. doi: 10.1038/s41598-025-07739-3.
2
T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine.接种mRNA新冠疫苗的西班牙裔美国人对高度保守的新冠病毒2型表位的T细胞反应。
Hum Vaccin Immunother. 2025 Dec;21(1):2501844. doi: 10.1080/21645515.2025.2501844. Epub 2025 May 23.
3
Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19.

本文引用的文献

1
Relative COVID-19 Viral Persistence and Antibody Kinetics.新型冠状病毒肺炎病毒的相对持续存在及抗体动力学
Pathogens. 2021 Jun 13;10(6):752. doi: 10.3390/pathogens10060752.
2
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.新冠病例中SARS-CoV-2表位的T细胞免疫显性和免疫流行率的综合分析。
Cell Rep Med. 2021 Feb 16;2(2):100204. doi: 10.1016/j.xcrm.2021.100204. Epub 2021 Jan 26.
3
Adaptive immunity to SARS-CoV-2 and COVID-19.对 SARS-CoV-2 和 COVID-19 的适应性免疫。
嵌合受体结合域疫苗设计与序贯免疫增强了针对新冠病毒的广泛中和抗体反应。
Front Immunol. 2025 Mar 27;16:1543212. doi: 10.3389/fimmu.2025.1543212. eCollection 2025.
4
T cell receptor usage and epitope specificity amongst CD8 and CD4 SARS-CoV-2-specific T cells.新冠病毒特异性CD8和CD4 T细胞中的T细胞受体使用情况及表位特异性
Front Immunol. 2025 Feb 28;16:1510436. doi: 10.3389/fimmu.2025.1510436. eCollection 2025.
5
PEPSeek-Mediated Identification of Novel Epitopes From Viral and Bacterial Pathogens and the Impact on Host Cell Immunopeptidomes.PEPSeek介导的病毒和细菌病原体新型表位鉴定及其对宿主细胞免疫肽组的影响
Mol Cell Proteomics. 2025 Apr;24(4):100937. doi: 10.1016/j.mcpro.2025.100937. Epub 2025 Mar 3.
6
Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis.从记忆 T 细胞中无需合成肽段即可鉴定病毒表位和反应性 T 细胞受体。
Commun Biol. 2024 Nov 4;7(1):1432. doi: 10.1038/s42003-024-07048-x.
7
T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.T 细胞肽预测、免疫反应以及接种疫苗和从轻度 COVID-19 中康复的受试者中的宿主-病原体关系。
Biomolecules. 2024 Sep 26;14(10):1217. doi: 10.3390/biom14101217.
8
Investigation of Long-Term CD4+ T Cell Receptor Repertoire Changes Following SARS-CoV-2 Infection in Patients with Different Severities of Disease.不同疾病严重程度的新冠病毒感染患者感染后长期CD4+ T细胞受体库变化的研究
Diagnostics (Basel). 2024 Oct 19;14(20):2330. doi: 10.3390/diagnostics14202330.
9
The molecular mechanisms of CD8 T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions.TCR-pMHC 相互作用介导的 CD8 T 细胞对 SARS-CoV-2 感染的分子机制。
Front Immunol. 2024 Oct 10;15:1468456. doi: 10.3389/fimmu.2024.1468456. eCollection 2024.
10
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes.绘制七种 SARS-CoV-2 抗原在常见 HLA 单倍型上的免疫肽组图谱。
Nat Commun. 2024 Aug 30;15(1):7547. doi: 10.1038/s41467-024-51959-6.
Cell. 2021 Feb 18;184(4):861-880. doi: 10.1016/j.cell.2021.01.007. Epub 2021 Jan 12.
4
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
5
Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19.新冠肺炎重症患者出院后的健康状况和症状。
J Gen Intern Med. 2021 Mar;36(3):738-745. doi: 10.1007/s11606-020-06338-4. Epub 2021 Jan 14.
6
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
7
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.轻度 COVID-19 后,SARS-CoV-2 特异性免疫记忆仍具有功能性。
Cell. 2021 Jan 7;184(1):169-183.e17. doi: 10.1016/j.cell.2020.11.029. Epub 2020 Nov 23.
8
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings.新冠病毒病症状:门诊环境中的纵向演变与持续情况
Ann Intern Med. 2021 May;174(5):723-725. doi: 10.7326/M20-5926. Epub 2020 Dec 8.
9
SARS-CoV-2 persistence and non-protective immunity in infected haematological patients.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)在感染血液系统疾病患者中的持续存在及非保护性免疫
Br J Haematol. 2021 Jan;192(2):e51-e54. doi: 10.1111/bjh.17212. Epub 2020 Nov 20.
10
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.感染 SARS-CoV-2 后持续疲劳很常见,且与初始感染的严重程度无关。
PLoS One. 2020 Nov 9;15(11):e0240784. doi: 10.1371/journal.pone.0240784. eCollection 2020.